Literature DB >> 11042665

Cyclosporin A-related cerebral vasculopathy.

R M Shbarou1, N J Chao, J C Morgenlander.   

Abstract

The use of cyclosporin A has been associated with several side-effects, including neurotoxicity. The mechanism of toxicity is not well known. We report two patients treated with cyclosporin A who developed lesions in the cerebral white matter associated with abnormally elevated cerebral blood flow velocities on transcranial doppler ultrasound and abnormal vascular appearance on magnetic resonance angiography. Bone Marrow Transplantation (2000) 26, 801-804.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11042665     DOI： 10.1038/sj.bmt.1702603

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  6 in total

1.  Vasospasm is a significant factor in cyclosporine-induced neurotoxicity: case report.

Authors:  Hilde M H Braakman; Jan Lodder; Alida A Postma; Lambert F R Span; Werner H Mess
Journal:  BMC Neurol       Date:  2010-05-11       Impact factor: 2.474

Review 2.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 3.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

4.  Transient increase of fractional anisotropy in reversible vasogenic edema.

Authors:  Shihoko Kimura-Ohba; Yi Yang; Jeffrey Thompson; Tomonori Kimura; Victor M Salayandia; Melissa Cosse; Yirong Yang; Laurel O Sillerud; Gary A Rosenberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-10       Impact factor: 6.200

5.  Accidental Overdose of Oral Cyclosporine in Haematopoietic Stem Cell Transplantation: A Case Report and Literature Review.

Authors:  Ali Tafazoli
Journal:  Drug Saf Case Rep       Date:  2015-12

6.  Posterior reversible encephalopathy syndrome associated with the use of chemotherapeutic agents: a rare complication after treatment with vinorelbine.

Authors:  Ines Gil; Filipa Serrazina; Miguel Pinto; Miguel Viana-Baptista
Journal:  BMJ Case Rep       Date:  2020-02-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.